Eli Lilly plans to make highly anticipated weight-loss pill at new $6.5B Texas plant
The $6.5 billion Houston-area plant is part of the drugmaker’s commitment to add four U.S. manufacturing sites through a $27 billion reshoring investment unveiled early this year.